Maturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes1

The mobilization of dendritic cells (DCs) from peripheral tissues is critical for the establishment of T cell-dependent immune responses or tolerance, because the physical interaction of DCs with naive T cells takes place in the T cell areas of lymph nodes. The autocrine/paracrine release of the high mobility group box 1 (HMGB1) nuclear protein by DCs controls the outcome of the DC–T cell interaction, influencing the priming/Th1 polarization of naive T cells. We herein present evidence that the receptor for advanced glycation end products (RAGE), a multiligand member of the Ig superfamily of cell-surface molecules that acts as a receptor for HMGB1, plays a nonredundant role in DC homing to lymph nodes. We used noninvasive imaging by magnetic resonance and immunohistochemistry to track DCs after s.c. injection in the footpad of wild-type+/+ or RAGE−/− mice. Maturing DCs expressing RAGE effectively migrated in both conditions. In contrast, RAGE−/− DCs failed to reach the draining popliteal lymph nodes of +/+ and −/− mice, indicating that the integrity of RAGE is required for DC mobilization. Thus the HMGB1-RAGE pathway is a checkpoint in DC maturation and function and a candidate for targeted therapies.

[1]  R. Steinman Linking innate to adaptive immunity through dendritic cells. , 2008, Novartis Foundation symposium.

[2]  J. Emond,et al.  Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress , 2007, Journal of leukocyte biology.

[3]  A. Krieg TLR9 and DNA 'feel' RAGE , 2007, Nature Immunology.

[4]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[5]  E. Chavakis,et al.  High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells , 2007, Circulation research.

[6]  M. Bianchi,et al.  The secretion of HMGB1 is required for the migration of maturing dendritic cells , 2007, Journal of leukocyte biology.

[7]  K. Tracey,et al.  High mobility group box‐1 protein induces the migration and activation of human dendritic cells and acts as an alarmin , 2007, Journal of leukocyte biology.

[8]  T. Scheenen,et al.  Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines , 2006, International journal of cancer.

[9]  D. Stern,et al.  RAGE in inflammation: a new therapeutic target? , 2006, Current opinion in investigational drugs.

[10]  Andreas Hess,et al.  In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice , 2006, European journal of immunology.

[11]  E. Ekland,et al.  Regulation of lymph node vascular growth by dendritic cells , 2006, The Journal of experimental medicine.

[12]  J. Villadangos,et al.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.

[13]  L. Ulloa,et al.  High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.

[14]  R. Donato,et al.  The Amphoterin (HMGB1)/Receptor for Advanced Glycation End Products (RAGE) Pair Modulates Myoblast Proliferation, Apoptosis, Adhesiveness, Migration, and Invasiveness , 2006, Journal of Biological Chemistry.

[15]  F. Ginhoux,et al.  B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006, Immunity.

[16]  A. Mantovani,et al.  Migration of dendritic cells across blood and lymphatic endothelial barriers , 2005, Thrombosis and Haemostasis.

[17]  A. Arbab,et al.  Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells , 2005, NMR in biomedicine.

[18]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[19]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[20]  M. Bianchi,et al.  Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells , 2005, European journal of immunology.

[21]  M. Bianchi,et al.  HMGB1: guiding immunity from within. , 2005, Trends in immunology.

[22]  Peter P. Nawroth,et al.  Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 , 2005, The Journal of Immunology.

[23]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[24]  A. Mantovani,et al.  Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin , 2005, The Journal of experimental medicine.

[25]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[26]  J. Kuja-Panula,et al.  Regulation of monocyte migration by amphoterin (HMGB1). , 2004, Blood.

[27]  M. Görner,et al.  Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. , 2004, Blood.

[28]  S. Müller,et al.  HMGB1 is an endogenous immune adjuvant released by necrotic cells , 2004, EMBO Reports.

[29]  K. Tracey,et al.  High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.

[30]  S. Rainbow,et al.  Advanced glycation end products modulate the maturation and function of peripheral blood dendritic cells. , 2004, Diabetes.

[31]  M. Bianchi,et al.  Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.

[32]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[33]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[34]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[35]  M. Andrassy,et al.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.

[36]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[37]  S. Lira,et al.  The Reduced Expression of 6ckine in the plt Mouse Results from the Deletion of One of Two 6ckine Genes , 1999, The Journal of experimental medicine.

[38]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[39]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[40]  P. Ricciardi-Castagnoli,et al.  Dendritic cell maturation and antigen presentation in the absence of invariant chain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Zinkernagel On observing and analyzing disease versus signals , 2007, Nature Immunology.

[42]  E. Rummeny,et al.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. , 2005, Radiology.